Bankrupt retail chain closing over 200 more stores

Rite Aid, currently undergoing its second Chapter 11 bankruptcy filing since October 2023, is seeking court approval to close an additional 232 stores across multiple states, bringing the total number of closures to 704. This action is part of a broader restructuring effort that may ultimately lead to the closure of all of Rite Aid's approximately 1,240 stores, reflecting continued struggles in the drugstore retail sector amid competition from larger chains and online pharmacies, as well as rising operational costs.

Analysis

Rite Aid's financial distress is escalating, marked by its second Chapter 11 bankruptcy filing on May 5, 2025, as New Rite Aid LLC, following an initial filing on October 15, 2023, during which it closed approximately 800 of its original 2,100 stores. The company is now pursuing court approval to shutter an additional 232 stores, part of a series totaling 704 closures announced under the current bankruptcy proceedings, with stated intentions to ultimately close its entire remaining footprint, estimated at about 1,240 stores. This situation unfolds against a backdrop of significant challenges in the drugstore retail sector, characterized by intense competition from other major chains like CVS (CVS) and Walgreens (WBA), big-box retailers such as Walmart (WMT), Target (TGT), and Costco (COST), and online platforms including Amazon (AMZN) and Mark Cuban's CostPlus Drug Company. Economic headwinds, including rising labor and product costs due to inflation and higher interest rates, are exacerbating these pressures. Notably, competitors are also undertaking substantial footprint reductions: CVS announced plans in 2021 to close 900 of its nearly 9,900 stores by the end of 2024, while Walgreens, which operates roughly 8,600 stores, has identified 1,200 locations for closure (500 in FY2025) and, as of March, had reportedly agreed to be sold to Sycamore Partners. The strongly negative general sentiment (-0.85) and specific negative sentiments for CVS (-0.4) and Walgreens (-0.6) underscore the pervasive difficulties within this industry segment.

Key Decisions for Investors

• Given Rite Aid's progression through a second Chapter 11 bankruptcy and stated plans to potentially close all stores, investors should assume a high probability of minimal to no recovery for equity holders and substantial risk for debt instruments.
• Investors in competing pharmacy chains such as CVS and Walgreens should monitor whether Rite Aid's market exit translates into tangible market share gains, while remaining cognizant that these competitors are also implementing significant store closure programs reflecting sector-wide pressures.